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Zika and dengue viruses are members of the Flavivirus genus that cause mild fever, rash and general body
pain; but can cause severe reactions, as hemorrhages (dengue virus), congenital syndrome (Zika virus), or even
death. Because of the structural similarity between these viruses, some antibodies generated after an infection
can cross-react with different members of the flavivirus family. After a secondary infection, the cross-reactive
antibodies can lead to more severe forms of the disease, through a mechanism named antibody-dependent
enhancement of infection (ADE). Broadly neutralizing antibodies are antibodies that neutralize both, dengue and
Zika viruses; and it has been demonstrated that they do not induce ADE. These antibodies are directed to a
discontinuous quaternary epitope named the Envelope Dimer Epitope (EDE)1, located in the envelope (E)
protein. To obtain the EDE, it is necessary to express the complete E protein, which contains other epitopes that
induce ADE. This study aims to generate a peptide that emulates the EDE epitope structure (mimotope) in order
to be used as a dual vaccine against dengue and Zika viruses; without causing ADE.
Using the broadly neutralizing antibody EDE1 C8, that does not induce ADE at high titers 2,3, and a phage
display library, we identified three peptides that are recognized by EDE1 C8, but share very low or no identity
with the E protein sequence from dengue and Zika viruses. Thus, they are probably emulating the
structure of the EDE epitope and are EDE mimotopes. The analysis by circular dichroism of the free peptides
showed mainly a random coil folding, characterized by a lack of secondary structure. EDE1 C8 did not
recognize these mimotopes attached chemically to a carrier protein, and free or phage-displayed peptides did
not induce antibodies against native viruses when administered to mice. To improve the stability and folding of
the peptides, we designed and produced adeno-associated virus-like particles (VLPs) that display the
mimotopes on their surface. VLPs were obtained using the baculovirus-insect cell system, with similar size and
structure to the native adeno-associated virus, as determined
by cryo-electron microscopy. The modified VLPs were
recognized by the EDE1 C8 antibody in a native Dot-Blot, but
not under denaturing conditions, demonstrating that the threedimensional structural conformation of the peptides displayed in
the VLPs can mimetize the EDE epitope. The VLPs displaying
mimotope 2, in combination with an adjuvant, elicited
antibodies against Zika and dengue viruses when applied to
mice.
Figure 1- Cryo-EM map of VLPs displaying mimotope 2, colored by radius (a) or showing the site of insertion in
red (b).
Here, we demonstrate that it is possible to emulate a very conserved epitope in dengue and Zika viruses, with
non-related to protein E peptides. This information is valuable for the design of a safer dengue and Zika vaccine
without ADE. More research is necessary and undergoing to study the neutralizing and ADE effect of the
antibodies produced in response to the immunization with these VLPs-displayed mimotopes.
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